ÂÜÀòÂÒÂ×

Ernie Maynard is a seasoned professional in the field of analytical development, currently serving as Senior Director, Analytical Development, and CMC Analytical Advisor at Novavax since September 2021. Prior roles include Director of Analytical Development at Arcellx, Inc., Principal Scientist at Catalent Pharma Solutions and NOVAVAX INC, and Scientist at the National Institutes of Health focusing on sequence data analysis. Ernie's academic background features significant contributions as an Assistant Professor at the Uniformed Services University of the Health Sciences and as a NRSA Postdoctoral Fellow at Johns Hopkins University, emphasizing protein interactions and thermodynamics research. Ernie holds a Ph.D. in Chemistry and Biochemistry and a B.S. in Chemistry from Texas A&M University.